Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Sep;90(3):1023–1031. doi: 10.1172/JCI115915

Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression.

J D Firth 1, P J Ratcliffe 1
PMCID: PMC329959  PMID: 1522210

Abstract

To determine the organ distribution of production of the three endothelin (ET) isopeptides, we have developed three ribonuclease protection assays specific for the messenger RNAs (mRNAs) of rat ETs 1, 2, and 3.12 organs from adult Sprague-Dawley rats were examined: heart, lung, liver, spleen, kidney, stomach, small intestine, large intestine, testis, muscle, salivary gland, and brain. The mRNA for ET1 was five times more abundant in the lung than in any other organ studied, moderate expression was seen in the large intestine, and lower levels of mRNA were detected in each of the other organs examined. ET2 was expressed at high level in both large and small intestine and at low level in stomach, muscle, and heart, but ET2 mRNA could not be detected elsewhere. ET3 mRNA was found in all organs, particularly in small intestine, lung, kidney, and large intestine. Because of reports suggesting that ETs might be involved in the hypoperfusion and hypofiltration observed in postischemic kidneys, we have also studied levels of mRNA in kidneys that had previously been subjected to 25 or 45 min of clamping of the renal pedicle. At 6 h after 45 min of ischemia, ET1 mRNA increased to a peak of 421 +/- 69% (mean +/- SEM, n = 3) of that in a standard renal RNA preparation. By contrast, ET3 mRNA decreased in the postischemic organ, falling to a value of 19 +/- 2% of standard at the same time point. The effects of ischemia on ET1 and ET3 mRNAs were long-lasting, with elevation of ET1 and depression of ET3 persisting for days. ET2 mRNA remained undetectable throughout. These findings (a) support a role for ET1 in postischemic renal vascular phenomena and (b) demonstrate a situation in which the expression of ET isoforms is clearly subject to differential regulation.

Full text

PDF
1023

Images in this article

1026Image
on p.1026
1027Image
on p.1027
1028Image
on p.1028
1028Image
on p.1028
1029Image
on p.1029
1030Image
on p.1030

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloch K. D., Eddy R. L., Shows T. B., Quertermous T. cDNA cloning and chromosomal assignment of the gene encoding endothelin 3. J Biol Chem. 1989 Oct 25;264(30):18156–18161. [PubMed] [Google Scholar]
  2. Bloch K. D., Friedrich S. P., Lee M. E., Eddy R. L., Shows T. B., Quertermous T. Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem. 1989 Jun 25;264(18):10851–10857. [PubMed] [Google Scholar]
  3. Bloch K. D., Hong C. C., Eddy R. L., Shows T. B., Quertermous T. cDNA cloning and chromosomal assignment of the endothelin 2 gene: vasoactive intestinal contractor peptide is rat endothelin 2. Genomics. 1991 May;10(1):236–242. doi: 10.1016/0888-7543(91)90505-9. [DOI] [PubMed] [Google Scholar]
  4. Firth J. D., Ratcliffe P. J., Raine A. E., Ledingham J. G. Endothelin: an important factor in acute renal failure? Lancet. 1988 Nov 19;2(8621):1179–1182. doi: 10.1016/s0140-6736(88)90243-7. [DOI] [PubMed] [Google Scholar]
  5. Hartter E., Woloszczuk W. Radioimmunoassay of endothelin. Lancet. 1989 Apr 22;1(8643):909–909. doi: 10.1016/s0140-6736(89)92915-2. [DOI] [PubMed] [Google Scholar]
  6. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Inoue A., Yanagisawa M., Takuwa Y., Mitsui Y., Kobayashi M., Masaki T. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem. 1989 Sep 5;264(25):14954–14959. [PubMed] [Google Scholar]
  8. Katoh T., Chang H., Uchida S., Okuda T., Kurokawa K. Direct effects of endothelin in the rat kidney. Am J Physiol. 1990 Feb;258(2 Pt 2):F397–F402. doi: 10.1152/ajprenal.1990.258.2.F397. [DOI] [PubMed] [Google Scholar]
  9. Kitamura K., Tanaka T., Kato J., Eto T., Tanaka K. Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem Biophys Res Commun. 1989 May 30;161(1):348–352. doi: 10.1016/0006-291x(89)91603-3. [DOI] [PubMed] [Google Scholar]
  10. Kon V., Yoshioka T., Fogo A., Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest. 1989 May;83(5):1762–1767. doi: 10.1172/JCI114079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MacCumber M. W., Ross C. A., Glaser B. M., Snyder S. H. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7285–7289. doi: 10.1073/pnas.86.18.7285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Melton D. A., Krieg P. A., Rebagliati M. R., Maniatis T., Zinn K., Green M. R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 1984 Sep 25;12(18):7035–7056. doi: 10.1093/nar/12.18.7035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Miller W. L., Redfield M. M., Burnett J. C., Jr Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest. 1989 Jan;83(1):317–320. doi: 10.1172/JCI113876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nunez D. J., Brown M. J., Davenport A. P., Neylon C. B., Schofield J. P., Wyse R. K. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest. 1990 May;85(5):1537–1541. doi: 10.1172/JCI114601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ohkubo S., Itoh Y., Kimura C., Onda H., Fujino M. Nucleotide sequence of a rabbit genomic DNA encoding mature endothelin-3. Nucleic Acids Res. 1990 Jan 25;18(2):374–374. doi: 10.1093/nar/18.2.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Padgett R. A., Grabowski P. J., Konarska M. M., Seiler S., Sharp P. A. Splicing of messenger RNA precursors. Annu Rev Biochem. 1986;55:1119–1150. doi: 10.1146/annurev.bi.55.070186.005351. [DOI] [PubMed] [Google Scholar]
  17. Pernow J., Hemsén A., Lundberg J. M. Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun. 1989 Jun 15;161(2):647–653. doi: 10.1016/0006-291x(89)92648-x. [DOI] [PubMed] [Google Scholar]
  18. Potter C. G., Tan C. C., Ratcliffe P. J. Quantification of 32P-labeled samples in gel fragments using the flat-bed liquid scintillation counter. Anal Biochem. 1991 Aug 15;197(1):121–124. doi: 10.1016/0003-2697(91)90366-2. [DOI] [PubMed] [Google Scholar]
  19. Ratcliffe P. J., Jones R. W., Phillips R. E., Nicholls L. G., Bell J. I. Oxygen-dependent modulation of erythropoietin mRNA levels in isolated rat kidneys studied by RNase protection. J Exp Med. 1990 Aug 1;172(2):657–660. doi: 10.1084/jem.172.2.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Saida K., Mitsui Y., Ishida N. A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity. J Biol Chem. 1989 Sep 5;264(25):14613–14616. [PubMed] [Google Scholar]
  21. Shibouta Y., Suzuki N., Shino A., Matsumoto H., Terashita Z., Kondo K., Nishikawa K. Pathophysiological role of endothelin in acute renal failure. Life Sci. 1990;46(22):1611–1618. doi: 10.1016/0024-3205(90)90392-5. [DOI] [PubMed] [Google Scholar]
  22. Simonson M. S., Dunn M. J. Cellular signaling by peptides of the endothelin gene family. FASEB J. 1990 Sep;4(12):2989–3000. doi: 10.1096/fasebj.4.12.2168326. [DOI] [PubMed] [Google Scholar]
  23. Yanagisawa M., Inoue A., Ishikawa T., Kasuya Y., Kimura S., Kumagaye S., Nakajima K., Watanabe T. X., Sakakibara S., Goto K. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6964–6967. doi: 10.1073/pnas.85.18.6964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  25. Yoshimi H., Hirata Y., Fukuda Y., Kawano Y., Emori T., Kuramochi M., Omae T., Marumo F. Regional distribution of immunoreactive endothelin in rats. Peptides. 1989 Jul-Aug;10(4):805–808. doi: 10.1016/0196-9781(89)90117-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES